³Ô¹ÏÍøÕ¾

Latest pre-clinical News

AdvanCell Successfully Completes an Oversubscribed US$112M Series C Financing
New link revealed between hypertension and the gut
New EU Consortium To Tackle Marburg Virus
New Grants Program Boosting Women’s Health Research
Nature may provide the key to beating drug resistant melanoma
Brains Bioceutical Expands Industry-Leading Cannabinoid Offering with D9-THC and CBN, Unveiling New Frontiers for Drug Development
New Study Sheds Light On Progressive Supranuclear Palsy
Governor of Queensland visit to Institute for Biomedicine and Glycomics highlights innovative malaria vaccine research
Does menopause hormone therapy increase or decrease your risk of dementia? Here’s the science
La Trobe Opens Front Door In Heart Of Bendigo
Life-changing cream to treat skin cancer moves closer to reality
Alzheimer’s disease: toxic protein is turned bad by immune enzyme, mouse study shows
New Oral Drug To Calm Abdominal Pain
Researchers discover localised pain relief using known chemical reaction
New treatment for boosting immune tolerance offers hope for early pregnancy loss
New technology saves the lives of patients with fatal skin reactions
Cancer drug offers hope for cardiovascular patients: Breakthrough from the Centre for PAD
Hoarding disorder: ‘sensory CBT’ treatment strategy shows promise
Hoarding disorder: ‘sensory CBT’ treatment strategy shows promise
Scientists discover a new understanding of how an old hormone works, paving way for better therapies for metabolic disease
INBRAIN Neuroelectronics Announces World’s First Human Graphene-Based Brain Computer Interface Procedure
New global guidance puts forward recommendations for more effective and equitable clinical trials
Accelerating Pioneering Inflammatory Diseases Research
Immune cells key in blood vessel damage, neurodegeneration
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
Breakthrough in the hunt for broad-spectrum malaria therapy
Associate Professor Belamy Cheung’s targeted treatment for aggressive childhood cancers
Two-in-one breakthrough: Cutting-edge immunotherapy could hold promise for incurable brain cancer
Researchers develop ground-breaking immunotherapy for aggressive brain cancer
Life science sector has major opportunity to embrace new tech, says leading expert
MRFF Funding Advances Hudson Institute RNA Therapies
UQ research reveals exercise brain boost can last for years
New Strategy Can Improve Cell Therapy Against Cancer
Scientists exploring more targeted radiation for glioblastoma
Alzheimer’s disease may begin when brain no longer creates mature brain cells
Research Transforming Pelvic Organ Prolapse Treatments
Research Funding For Ovarian Cancer Treatment
Telix completes proof-of-concept study of TLX592 in prostate cancer
UQ Develops New Drug For Sepsis
Tissue And Motion Conference 2024
Uncovering Drivers That Cause Type 1 Diabetes
Royal Grant For ALS Research
World first: Zebrafish discovery to speed testing of MND and dementia treatments
Global Search For Missing Glaucoma Link
Invion announces positive results from pre-clinical study of INV043
Common Veggie Could Help Prevent And Treat Stroke
Mouth to mouth tactic may stop dental decay
Trial for potential rheumatoid arthritis treatment begins